Navigation Links
Creatinine, Body Fluid

ProductsCreatinine, Body Fluid
Company ARUP Laboratories
Item Creatinine, Body Fluid
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Creatinine, 24-Hour Urine
2. Creatinine, Random Urine
3. Creatinine, Serum or Plasma
4. Storz Fluid Filter - 0.2 micron
5. Storz Fluid Filter - 0.45 micron
6. Subretinal Fluid Cannula - Curved
7. Subretinal Fluid Cannula - Straight
8. Viscous Fluid Cannula
9. BD Visitec Fluid Collection Products
10. BD Visitec Subretinal Fluid Instruments
11. Subretinal Fluid Cannula
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide.
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide.
...ment Set offers maximum distraction with minimal n...y the Tangent Posterior Impacted Instrument Set ar...reproduce the technique. Set offers 9 different di...istraction. A variety of sizes of round scrapers, ...
Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position.
Medicine Products:
(Date:10/7/2008)...a Youth in Houston and San ...Carlson Hotels Worldwide and the,American Red Cros...ity bags,to children displaced by Hurricane Ike in...ctivity book, colored pencils, stickers, sunglasse...i-bin/prnh/20081007/AQTU541 ), "We wanted to prov...
(Date:10/7/2008)... -- Majesco Entertainment,Company (Nasdaq: COOL )...ss,market, today announced that Jillian Michaels, ...led to ship on October 21st for Wii(TM). The game ...fitness trainer --- Jillian,Michaels, the strength...series "The Biggest Loser" --- with the Wii(TM) sy...
(Date:10/7/2008)...Call/ -- Stallergenes S.A.,today announced that th...atalent for the promotion and distribution in Euro...eloped and co-manufactured by Catalent and,The Med...e pre-filled with adrenaline, which,will be availa..., in an,autoinjector device. The Medical House has...
(Date:10/7/2008)... Medical Devices Inc.,(CleveMed) announced it has ...unding from the National Institute on Aging to dev...r programming in deep brain,stimulation (DBS) proc...ollaborating with clinicians at the Center for Neu...dation, a world renowned, pioneering DBS surgery,c...
Breaking Medicine News(10 mins):Health News:Carlson Hotels Worldwide Partners With the American Red Cross in Texas to Provide Relief for Children Affected by Hurricane Ike 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2
...ing out of control, 'in'? A new report by the Ame...sy with reports of college girls and their wild (s... has revealed that breaking out of control and goi...ing fun in life. Three out of four women seem to g...
...art is under pressure as it is asked to improve it...llary Rodham Clinton who has had deep// ties with ...linton served on Wal-Mart's board of directors for...er time on the board of Wal-Mart was a memorable o...
...'s joy and relief at Norfolk as surgeons at the No...ven the green signal to make available the breast/... for her-2 gene. "We made the business case and ... groups, and the primary care trusts have backed t...
...esearch by the British Heart Foundation says that ... to fall a victim to heart disease than people// o...type 2 diabetes as compared to 3 percent of the ge...ate concern are the high rates of untreated diabet...
Other Medicine News:
(Date:10/7/2008)..., Va., Oct. 7 /- CEL-SCI Co...s entered into a Material Transfer,Agreement (MTA)...enter,(NIHCC) and the laboratory of Dr. Francesco ...asis of changes to the tumor microenvironment,caus...la is the Chief of,the Infectious Disease and Immu...
(Date:10/7/2008)...DGE, Mass., Oct. 7 /- Taligen Therape...veral of the Company,s pipeline,candidates were pr...hop in,Basel, Switzerland. The data highlighted th... complement-mediated diseases., "These highlighte...es,presented at the conference, reveal the deep ex...
(Date:10/7/2008)...EGO, Oct. 7 /- Ardea Biosci...a poster entitled "RDEA119, a Potent,and Highly Se...Sulfate,Sodium (DSS) -- induced Chronic Colitis in...astroenterology (ACG) 2008 Annual Meeting in Orlan...a preclinical study of,RDEA119, the Company,s lead...
(Date:10/6/2008)...and CHIPPENHAM, England, October 7 /PRNewswire-Fir...others Index: 4565) and Vectura,Group plc ("Vectur...udies,evaluating the efficacy, safety and tolerabi... the European Respiratory Society (ERS) in Berlin,...onium bromide), a novel,inhaled long-acting muscar...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Carnegie Mellon urges industry to broaden carbon footprint calculations 4482 1Carnegie Mellon urges industry to broaden carbon footprint calculations 4482 2XENAZINE 28R 29 28Tetrabenazine 29 Approved by FDA for Patients with Chorea Associated with Huntingtons Disease 25458 1XENAZINE 28R 29 28Tetrabenazine 29 Approved by FDA for Patients with Chorea Associated with Huntingtons Disease 25458 2XENAZINE 28R 29 28Tetrabenazine 29 Approved by FDA for Patients with Chorea Associated with Huntingtons Disease 25458 3Older Adults Reluctant to Question Surgical Treatment 25455 1Older Adults Reluctant to Question Surgical Treatment 25455 2Caltech engineers build mini drug producing biofactories in yeast 4479 1Caltech engineers build mini drug producing biofactories in yeast 4479 2
...ATION, Fla., May 08, 2007 /PRNewswire-FirstCall/ -...day announced,results from a sponsored in vitro st...found that Multiferon(R) (multi-,subtype, human al...t human melanoma clones to a far greater degree th...n accepted for,publication in AntiCancer Research,...
...Scientific Presentation for Pristiq Occurs at the ...ge of Obstetricians and,Gynecologists, COLLEGEVILL...th,Pharmaceuticals, a division of Wyeth , presente...g Pristiq(TM) (desvenlafaxine) for,the treatment o...es,and night sweats) associated with menopause. Th...
Other Medicine Technology:Multiferon Shows Potent Activity in Preventing the Progression of,Malignant Melanoma; Study to be Published 2Multiferon Shows Potent Activity in Preventing the Progression of,Malignant Melanoma; Study to be Published 3Multiferon Shows Potent Activity in Preventing the Progression of,Malignant Melanoma; Study to be Published 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6